Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018882 |
---|---|
Receipt number | R000021841 |
Scientific Title | Phase II trial of bolus 5-FU/l-LV regimen as salvage line chemotherapy for oral fluorouracil resistant unresectable gastric cancer (HGCSG1502) |
Date of disclosure of the study information | 2015/09/01 |
Last modified on | 2022/09/07 18:03:59 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/09/01 22:39:01 | ||
2 | Update | 2015/09/02 13:32:09 | Acronym Acronym |
|
3 | Update | 2015/09/02 13:43:32 | Interventions/Control_1 Interventions/Control_1 |
|
4 | Update | 2015/09/02 13:48:16 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2015/11/18 13:21:13 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
6 | Update | 2015/11/18 13:32:24 | Public title |
|
7 | Update | 2015/12/13 16:54:48 | Other related information |
|
8 | Update | 2016/02/17 16:22:18 | Other related information |
|
9 | Update | 2016/07/24 15:39:42 | Other related information |
|
10 | Update | 2016/08/17 12:14:05 | Name of primary person or sponsor Organization |
|
11 | Update | 2017/09/02 11:47:03 | Other related information |
|
12 | Update | 2018/03/03 10:13:44 | Other related information |
|
13 | Update | 2018/09/03 22:35:48 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Other related information |
|
14 | Update | 2019/09/15 15:25:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
15 | Update | 2019/09/15 15:29:54 | Publication of results Number of participants that the trial has enrolled Results Results Results date posted |
|
16 | Update | 2019/09/15 15:30:57 | Date of IRB Date analysis concluded |
|
17 | Update | 2020/03/05 18:59:30 | URL releasing protocol URL related to results and publications Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
18 | Update | 2020/09/04 19:54:30 | Other related information |
|
19 | Update | 2021/03/07 08:43:13 | Other related information |
|
20 | Update | 2022/09/07 18:03:59 | Recruitment status |